1,188 filings
Page 5 of 60
8-K
w51 5uxkpcdas
31 Dec 19
Entry into a Material Definitive Agreement
7:36am
8-K
grcbn 5p32
18 Dec 19
VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Adolescents with Obesity
7:35am
CT ORDER
edpiwd oumn
13 Dec 19
Confidential treatment order
4:26pm
8-K
hpb xm4i45reukjy
20 Nov 19
Other Events
7:35am
4
v9xa97
18 Nov 19
VIVUS / Mark K Oki ownership change
4:51pm
4
nd3cg
18 Nov 19
VIVUS / Santosh T Varghese ownership change
4:51pm
CT ORDER
hwg nshms
14 Nov 19
Confidential treatment order
1:28pm
8-K
jwu xi9hr
8 Nov 19
VIVUS, Inc. Q3 2019 Earnings Conference Call
4:11pm
8-K
d97nn3sar7a bafc8h
5 Nov 19
VIVUS Reports Third Quarter 2019 Financial Results
4:10pm
8-K
kgidgb8 h4
28 Oct 19
VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
7:35am
8-K
5jdz7kjyh8gqmu
21 Oct 19
VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit
7:35am
8-K
e6a45zuddc58wc
7 Oct 19
VIVUS Announces Acceptance of Qsymia Decentralized Marketing Authorization Application in Europe
7:35am
8-K
95yhznfn dah9hf39dv
3 Oct 19
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
7:36am
8-K
0cd0qmtfpgiins
5 Sep 19
Regulation FD Disclosure
7:31am
8-K
2vvus
27 Aug 19
Other Events
7:36am
8-K
vxz3tw2g2
20 Aug 19
Other Events
7:35am
8-K
e5k7sfxl48i 994
9 Aug 19
VIVUS, Inc. Q2 2019 Earnings Conference Call
4:05pm
S-8
7h9a138 u85co07v
6 Aug 19
Registration of securities for employees
4:52pm
8-K
pe2mclrermf66b
6 Aug 19
VIVUS Reports Second Quarter 2019 Financial Results
4:10pm